The impact of coexisting fibromyalgia syndrome on disease activity in patients with psoriatic arthritis and rheumatoid arthritis: A cross-sectional study

References

• Binkiewicz-Glińska A, Bakuła S, Tomczak H, Landowski J, Ruckemann-Dziurdzińska K, Zaborowska-Sapeta K, et al. Fibromyalgia syndrome—a multidisciplinary approach. Psychiatr Pol. 2015;49(4):801–10.
   PubMed Web of Science ®Google Scholar
• Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547–55.
   PubMed Web of Science ®Google Scholar
• Haliloglu S, Carlioglu A, Akdeniz D, Karaaslan Y, Kosar A. Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int. 2014;34(9):1275–80.
   PubMed Web of Science ®Google Scholar
• Tsilioni I, Russell IJ, Stewart JM, Gleason RM, Theoharides TC. Neuropeptides CRH, SP, HK-1, and infammatory cytokines IL-6 and TNF are increased in serum of patients with fibromyalgia syndrome, implicating mast cells. J Pharmacol Exp Ther. 2016;356(3):664–72.
   PubMed Web of Science ®Google Scholar
• Bäckryd E, Tanum L, Lind AL, Larsson A, Gordh T. Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma. J Pain Res. 2017;10:515–25.
   PubMed Web of Science ®Google Scholar
• Coskun Benliday I. Fibromyalgia interferes with disease activity and biological therapy response in inflammatory rheumatic diseases. Rheumatol Int. 2020;40:849–58.
   PubMed Web of Science ®Google Scholar
• Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO. Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia. Int J Rheum Dis. 2018;21(3):639–46.
   PubMed Web of Science ®Google Scholar
• Moltó A, Etcheto A, Gossec L, Boudersa N, Claudepierre P, Roux N, et al. Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers’ effectiveness in axial spondyloarthritis: results of a prospective, multicenter study. Ann Rheum Dis. 2018;77(4):533–40.
   PubMed Web of Science ®Google Scholar
• Bello N, Etcheto A, Béal C, Dougados M, Moltó A. Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis. Arthritis Res Ther. 2016;18:42.
   PubMed Web of Science ®Google Scholar
• Macfarlane GJ, Pathan E, Siebert S, Packham J, Gaffney K, Choy E, et al. AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS). BMC Rheumatol. 2019;3:19.
   PubMedGoogle Scholar
• Macfarlane GJ, MacDonald RIR, Pathan E, Siebert S, Gaffney K, Choy E, et al. Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register . Rheumatology. 2018;57(11):1982–90.
   PubMed Web of Science ®Google Scholar
• Macfarlane GJ, Barnish MS, Pathan E, Martin KR, Haywood KL, Siebert S, et al. Co-occurrence and characteristics of patients with axial spondyloarthritis who meet criteria for fibromyalgia: results from a UK National Register. Arthritis Rheumatol. 2017;69(11):2144–50.
   PubMed Web of Science ®Google Scholar
• Wach J, Letroublon MC, Coury F, Tebib JG. Fibromyalgia in spondyloarthritis: effect on disease activity assessment in clinical practice. J Rheumatol. 2016;43(11):2056–63.
   PubMed Web of Science ®Google Scholar
• Chakr RMDS, Brenol C, Ranzolin A, Bernardes A, Dalosto AP, Ferrari G, et al. Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia. Rev Bras Reumatol Engl Ed. 2017;57(5):403–11.
   PubMedGoogle Scholar
• Joharatnam N, McWilliams DF, Wilson D, Wheeler M, Pande I, Walsh DA. A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis. Arthritis Res Ther. 2015;17:11.
   PubMed Web of Science ®Google Scholar
• Fan A, Pereira B, Tournadre A, Tatar Z, Malochet-Guinamand S, Mathieu S, et al. Frequency of concomitant fbromyalgia in rheumatic diseases: monocentric study of 691 patients. Semin Arthritis Rheum. 2017;47(1):129–32.
   PubMed Web of Science ®Google Scholar
• Lage-Hansen PR, Chrysidis S, Lage-Hansen M, Hougaard A, Ejstrup L, Amris K. Concomitant fbromyalgia in rheumatoid arthritis is associated with the more frequent use of biological therapy: a cross-sectional study. Scand J Rheumatol. 2016;45(1):45–8.
   PubMed Web of Science ®Google Scholar
• Salaffi F, Di Carlo M, Carotti M, Sarzi-Puttini P. The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia. Rheumatol Int. 2018;38(10):1911–8.
   PubMed Web of Science ®Google Scholar
• Salaffi F, Gerardi MC, Atzeni F, Batticciotto A, Talotta R, Draghessi A, et al. The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis. Rheumatol Int. 2017;37(12):2035–42.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 1990;33(2):160–72.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Häuser W, Katz RS, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol. 2011;38(6):1113–22.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw D, Fitzcharles MA, Goldenberg D, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–10.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Häuser W, Katz RL, et al. 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46 (3):319–29.
   PubMed Web of Science ®Google Scholar
• Wolfe F. Stop using the American College of Rheumatology criteria in the clinic. J Rheumatol. 2003;30(8):1671–2.
   PubMed Web of Science ®Google Scholar
• Perrot S, Bouhassira D, Fermanian J. Cercled’Etude de la Douleur en Rhumatologie Cercled’Etude de la Douleur en Rhumatologie. Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST). Pain. 2010;150(2):250–6.
   PubMed Web of Science ®Google Scholar
• Celiker R, Altan L, Rezvani A, Aktas I, Tastekin N, Dursun E, et al. Reliability and validity of the Turkish version of the fibromyalgia rapid screening tool (FiRST). J Phys Ther Sci. 2017;29(2):340–4.
   PubMedGoogle Scholar
• Taylor W, Gladman DD, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665–73.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Clifton O, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.
   PubMed Web of Science ®Google Scholar
• Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91.
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988.
   Google Scholar
• Zhao SS, Duffield SJ, Goodson NJ. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract Res Clin Rheumatol. 2019;33(3):101423.
   PubMed Web of Science ®Google Scholar
• Duffield SJ, Miller N, Zhao S, Goodson NJ. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology. 2018;57(8):1453.
   PubMed Web of Science ®Google Scholar
• Brikman S, Furer V, Wollman J, Borok S, Matz H, Polachek A, et al. The effect of the presence of fibromyalgia on common clinical disease activity indices in patients with psoriatic arthritis: a cross-sectional study. J Rheumatol. 2016;43(9):1749e54.
   Web of Science ®Google Scholar
• D’Agostino MA, Olivieri I. Enthesitis. Best Pract Res Clin Rheumatol. 2006;20(3):473–86.
   PubMed Web of Science ®Google Scholar
• Graceffa D, Maiani E, Sperduti I, Ceralli F, Bonifati C. Clinical remission of psoriatic arthritis in patients receiving continuous biological therapies for 1 year: the experience of an outpatient dermatological clinic for psoriasis. Clin Exp Dermatol. 2015;40(2):136e41.
   Web of Science ®Google Scholar
• Fan A, Pereira B, Tournadre A, Tatar Z, Malochet-Guinamand S, Soubrier M, et al. Evaluation of the fibromyalgia rapid screening tool (FiRST) questionnaire to screen fibromyalgia associated with inflammatory rheumatic disease [abstract]. Annals of the Rheumatic Diseases 2016;75:388–389.
   Google Scholar
• Kılıçarslan A, Yurdakul FG, Bodur H. Diagnosing fibromyalgia in rheumatoid arthritis: the importance of assessing disease activity. Turk J Phys Med Rehabil. 2018;64(2):133–9.
   PubMed Web of Science ®Google Scholar
• Zammurrad S, Munir W, Farooqi A. Disease activity score in rheumatoid arthritis with or without secondary fibromyalgia. J Coll Physicians Surg Pak. 2013;23:413–7.
   PubMed Web of Science ®Google Scholar
• Abbasi L, Haidri FR. Fibromyalgia complicating disease management in rheumatoid arthritis. J Coll Physicians Surg Pak. 2014;24:424–7.
   PubMed Web of Science ®Google Scholar
• Pollard LC, Kingsley GH, Choy EH, Scott DL. Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology. 2010;49(5):924–8.
   PubMed Web of Science ®Google Scholar